Clinical Operations

The Clinical Operations team at Intellia Therapeutics is responsible for the planning, execution, and oversight of clinical trials to assess the safety and efficacy of gene editing therapies. This multidisciplinary team collaborates closely with regulatory affairs, medical writing, and drug safety professionals to ensure compliance and optimize trial performance, ultimately aiming to bring innovative treatments to patients with serious conditions. Their collective expertise in clinical research and regulatory strategy helps navigate the complex landscape of gene therapy development.